# Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Exercise Performance

> **NCT02143687** · PHASE4 · COMPLETED · sponsor: **University of Zurich** · enrollment: 30 (actual)

## Conditions studied

- Precapillary Pulmonary Hypertension
- Interstitial Lung Disease

## Interventions

- **BEHAVIORAL:** Moderate altitude sojourn
- **BEHAVIORAL:** Low altitude sojourn
- **DRUG:** Oxygen
- **DRUG:** Sham oxygen (room air)

## Key facts

- **NCT ID:** NCT02143687
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2021-10
- **Final completion:** 2021-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02143687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02143687, "Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Exercise Performance". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02143687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*